Mitochondrial dysfunction in neurodegenerative diseases
Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evid...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 342; no. 3; pp. 619 - 630 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
The American Society for Pharmacology and Experimental Therapeutics
01.09.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evidence has emerged for impaired mitochondrial dynamics (shape, size, fission-fusion, distribution, movement etc.) in neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Here, we provide a concise overview of the major findings in recent years highlighting the importance of healthy mitochondria for a healthy neuron. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0022-3565 1521-0103 |
DOI: | 10.1124/jpet.112.192138 |